Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination

被引:66
作者
de Smit, AJ [1 ]
Bouma, A [1 ]
de Kluijver, EP [1 ]
Terpstra, C [1 ]
Moormann, RJM [1 ]
机构
[1] Inst Anim Sci & Hlth ID Lelystad, Dept Mammalian Virol, NL-8200 AB Lelystad, Netherlands
关键词
classical swine fever virus; marker vaccine; duration of protection;
D O I
10.1016/S0378-1135(00)00306-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The period during which pigs are protected after vaccination is important for the successful usage of a marker vaccine against classical swine fever virus (CSFV) in an eradication programme. In four animal experiments with different vaccination-challenge intervals we determined the duration of protection of an E2 subunit marker vaccine in pigs after a single vaccination. Unvaccinated pigs were included in each group to detect transmission of the challenge virus. Three groups of six pigs were vaccinated once and subsequently inoculated with the virulent CSFV strain Brescia after a vaccination-challenge interval of 3, 51/2, 6 or 13 months. All vaccinated pigs, 16 out of 18, with neutralising antibodies against CSFV at the moment of challenge, 3, 51/2, 6 or 13 months later, survived, whereas unvaccinated control pigs died from acute CSF or were killed being moribund. A proportion of the vaccinated pigs did however develop fever or cytopenia after challenge and two vaccinated pigs were viremic after challenge. Virus transmission of vaccinated and challenged pigs to unvaccinated sentinel pigs did not occur in groups of pigs which were challenged 3 or 6 months after a single vaccination. Two out of eight vaccinated pigs that were found negative for CSFV neutralising antibody at 13 months after vaccination died after subsequent challenge. The findings in this study demonstrate that pigs can be protected against a lethal challenge of CSFV for up to 13 months after a single vaccination with an E2 subunit marker vaccine. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:307 / 317
页数:11
相关论文
共 34 条
[1]  
ADA G, 1997, VACCINES VACCINATION
[2]   REGULATION OF IGG ANTIBODY-TITERS BY THE AMOUNT OF PERSISTING IMMUNE-COMPLEXED ANTIGEN [J].
BACHMANN, MF ;
KUNDIG, TM ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2567-2570
[3]   Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease [J].
Bolin, SR ;
Ridpath, JF .
ARCHIVES OF VIROLOGY, 1996, 141 (08) :1463-1477
[4]   Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus [J].
Bouma, A ;
De Smit, AJ ;
De Jong, MCM ;
De Kluijver, EP ;
Moormann, RJM .
VACCINE, 2000, 18 (14) :1374-1381
[5]   Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus [J].
Bouma, A ;
de Smit, AJ ;
de Kluijver, EP ;
Terpstra, C ;
Moormann, RJM .
VETERINARY MICROBIOLOGY, 1999, 66 (02) :101-114
[6]   A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge [J].
Bruschke, CJM ;
Moormann, RJM ;
vanOirschot, JT ;
vanRijn, PA .
VACCINE, 1997, 15 (17-18) :1940-1945
[7]  
DAHLE J, 1995, BERL MUNCH TIERARZTL, V108, P20
[8]   Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine [J].
de Smit, AJ ;
Bouma, A ;
de Kluijver, EP ;
Terpstra, C ;
Moormann, RJM .
VETERINARY QUARTERLY, 2000, 22 (03) :150-153
[9]   Efficacy of an inactivated feline leukemia virus vaccine [J].
Hoover, EA ;
Mullins, JI ;
Chu, HJ ;
Wasmoen, TL .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (05) :379-383
[10]   GLYCOPROTEIN E1 OF HOG-CHOLERA VIRUS EXPRESSED IN INSECT CELLS PROTECTS SWINE FROM HOG-CHOLERA [J].
HULST, MM ;
WESTRA, DF ;
WENSVOORT, G ;
MOORMANN, RJM .
JOURNAL OF VIROLOGY, 1993, 67 (09) :5435-5442